67 results
8-K
EX-1.1
ANNX
Annexon Inc
7 Jun 24
Annexon Announces Pricing of $125 Million Underwritten Public Offering
4:42pm
source code, ideas, research and development information, know-how, formulas, compositions, technical data, designs, drawings, specifications
424B5
ANNX
Annexon Inc
6 Jun 24
Prospectus supplement for primary offering
9:57pm
focused primarily on performing research and development activities, hiring personnel and raising capital to support and expand these activities. We do … , preclinical studies and research and development programs, including the timing and availability of data from such studies;
the timing of commencement
424B5
ANNX
Annexon Inc
4 Jun 24
Prospectus supplement for primary offering
5:21pm
classical complement activation.
Since inception in 2011, we have focused primarily on performing research and development activities, hiring personnel … and clinical trials and research and development programs;
our ability to acquire, discover, develop and advance product candidates into, and successfully
8-K
EX-99.2
ANNX
Annexon Inc
4 Jun 24
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
7:05am
and clinical trials and research and development programs, timing of clinical results, anticipated timing of submission of a Biologics Licensing Application
8-K
EX-99.1
nnswkeyw2 fffy7qkjnc
13 May 24
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
4:05pm
424B5
u5eqmtou
5 Apr 24
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
rmrxjyik0ld xo
26 Mar 24
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
4:05pm
8-K
EX-99.1
vln6j
4 Mar 24
Regulation FD Disclosure
5:25pm
8-K
EX-1.1
4o41e mzxju
21 Dec 23
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
4:09pm
424B5
u1s nu7awxx
21 Dec 23
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
9wh6yebra
13 Nov 23
Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results
4:10pm
8-K
EX-99.1
cqtcd9td1
7 Aug 23
Annexon Highlights Recent Pipeline and Business Progress and Reports Second Quarter 2023 Financial Results
4:12pm
8-K
EX-99.1
c7sn82gx
8 May 23
Annexon Reports First Quarter 2023 Financial Results and Highlights Recent Pipeline Progress
4:11pm